In this article, we will list the 5 Stocks with Best Earnings Growth for the Next 10 Years. Please visit 10 Stocks with Best Earnings Growth for the Next 10 Years if you would like to see the extended list and the methodology behind it.
5. AppLovin Corporation (NASDAQ:APP)
Number of Hedge Fund Holders: 108
On May 7, Cory Carpenter, an analyst at JPMorgan, elevated the price target on AppLovin Corporation (NASDAQ:APP) to $515 from $500 and maintained a Neutral rating. This price hike came shortly after the company’s first-quarter beat.
In Q1, AppLovin Corporation (NASDAQ:APP) delivered a remarkable performance, outperforming EPS by $0.12 and $0.06 billion, respectively. Looking ahead, management projects revenue in the range of $1.915 billion to $1.945 billion and an adjusted EBITDA margin between 84% and 85%. Regarding its future projects, CEO Adam Foroughi said,
“Come June, advertisers across the world will be able to sign up for Axon and start running campaigns. That changes the trajectory of this company in a very meaningful way.”
TZIDO SUN/Shutterstock.com
Wall Street reacted positively to the first quarter report. On May 8, Deutsche Bank lifted the price target on AppLovin Corporation (NASDAQ:APP) to $660 from $640 and reiterated a Buy rating on May 8. A day earlier, Piper Sandler also raised the price target on the company to $665 from $650, citing the company’s largest percentage beat since Q1 2025. The firm has an Overweight rating on the stock.
AppLovin Corporation (NASDAQ:APP) is a California-based company that provides AI-powered solutions to help developers enhance the marketing and monetization of their content. Founded in 2011, the company operates through two segments: Advertising and Apps.
4. Oracle Corporation (NYSE:ORCL)
Number of Hedge Fund Holders: 111
On May 12, Brian Schwartz from Oppenheimer lifted the price target on Oracle Corporation (NYSE:ORCL) to $235 from $210 and reiterated an Outperform rating. While highlighting positive developments during the current quarter, which will strengthen its superior EPS compounder thesis, the firm named the company its top pick.
What stood out most was the robust technology infrastructure spending disclosed in the first-quarter report from the company’s key customers, partners, and suppliers. Oppenheimer believes solid bookings growth in Q4 will be from OpenAI, Meta, NVIDIA, and federal government commitments. Additionally, a demand increase due to favorable seasonality for the broader Oracle Corporation (NYSE:ORCL) product offering will drive further growth. Indeed, ORCL is one of the stocks with the best earnings growth for the next 10 years.
Back on May 4, IBM and Oracle Corporation (NYSE:ORCL) announced plans to expand their 40-year-long partnership to offer AI and hybrid cloud capabilities, with various integrated solutions scheduled for the remainder of 2026. The collaboration will integrate Oracle Fusion Cloud Enterprise Resource Planning and IBM Maximo Application Suite through a connector to help customers manage processes across several areas.
Oracle Corporation (NYSE:ORCL) is a Texas-based company that provides solutions for enterprise information technology environments. Incorporated in 1977, the company offers Oracle Cloud SaaS, Oracle Health applications, Oracle Cloud and on-premises licenses, and Oracle license support services.
3. MercadoLibre, Inc. (NASDAQ:MELI)
Number of Hedge Fund Holders: 113
On May 10, BTIG trimmed the price target on MercadoLibre, Inc. (NASDAQ:MELI) to $2,150 from $2,400 and reiterated a Buy rating after the first-quarter results. In a research note, the analyst said that the company surprised investors by revising its operating margins to approximately the 7% level seen in Q1. However, the firm expects the company’s investments will build a “bigger and even more dominant” platform in the long run.
Two days earlier, Benchmark lowered the price target on MercadoLibre, Inc. (NASDAQ:MELI) from $2,780 to $2,380 to better reflect flexible margin trends. The firm cited robust engagement, enhanced user growth, and ecosystem expansion as factors that helped keep asset quality stable. Investment intensity is expected to stay high in the near term, Benchmark noted. The firm has an unchanged Buy rating on the stock.
Although MercadoLibre, Inc. (NASDAQ:MELI) has significantly underperformed the S&P 500 over the past year, the company has a solid quarterly revenue growth (yoy) of 49% and ROE (ttm) of 31.26%. With a 1-year upside potential of 50.31%, the company is among the stocks with the best earnings growth for the next 10 years.
MercadoLibre, Inc. (NASDAQ:MELI), incorporated in 1999, is a Uruguay-based operator of online commerce platforms, including Mercado Libre Marketplace and Mercado Pago.
2. Eli Lilly and Company (NYSE:LLY)
Number of Hedge Fund Holders: 137
On May 5, Emily Field from Barclays lifted the price target on Eli Lilly and Company (NYSE:LLY) to $1,400 from $1,350 and maintained an Overweight rating following the first-quarter results. In a research note, the analyst stated that the company’s “strong tirzepatide momentum takes focus back to the big picture.”
Goldman Sachs, too, advises investors to concentrate on the bigger picture highlighted in the company’s Q1 earnings analysis. The firm reiterated a Buy rating on Eli Lilly and Company (NYSE:LLY) with a price target of $1,283. The firm said that the safety profile of Foundayo has been well established across 11,000 patients in Phase 3 trials, calling the stock weakness an overreaction.
In its earnings call, Eli Lilly and Company (NYSE:LLY) revised 2026 full-year revenue guidance to $82-85 billion, with the midpoint indicating 28% growth compared to 2025. The company’s non-GAAP EPS of $35.50-$37 is also higher than the previous estimate, thanks to its robust performance across major therapeutic areas. No wonder the company is one of the stocks with the best earnings growth for the next decade.
Eli Lilly and Company (NYSE:LLY) is an Indiana-based company specializing in human pharmaceutical products. Founded in 1876, the company offers products for cardiometabolic health, oncology, immunology, and migraine prevention.
1. Mastercard Incorporated (NYSE:MA)
Number of Hedge Fund Holders: 150
On May 5, BMO Capital reaffirmed an Outperform rating and a price target of $580 on Mastercard Incorporated (NYSE:MA). In its analysis, the firm highlighted the robust Q1 results, with the company delivering beats on both revenue and earnings.
While noting the company’s greater exposure to Middle East travel relative to its peers, BMO Capital said that Mastercard Incorporated (NYSE:MA) doesn’t have promising catalysts for the rest of the year. With that said, improved clarity on the end of the Iran tensions or favorable travel trends will be priced into the stock quickly in the months ahead. With a strong ROE, MA is among the stocks with the best earnings growth for the next 10 years.
Several other analysts revisited their stance on Mastercard Incorporated (NYSE:MA) after the first-quarter win. On May 2, Paul Golding, an analyst at Macquarie, cut the company’s price target to $665 from $675 and reiterated an Outperform rating. According to the firm, the consumer is “solid,” and Crypto, AI, and value-added services are the “key drivers.” UBS, too, lowered the price target on the company from $650 to $640 and maintained a Buy rating a day earlier.
Mastercard Incorporated (NYSE:MA) is a New York-based financial technology company that offers payment-related products and services. Founded in 1966, the company serves a diverse range of customers, including individuals, digital partners, businesses, financial institutions, and governments.
While we acknowledge the potential of MA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MA and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: Starter Stock Portfolio: 14 Safe Stocks to Buy Now and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026.
Disclosure: None.
